SYRS

Syros Pharmaceuticals, Inc. Common Stock

Delisted

SYRS was delisted on the 19th of March, 2025.

100 hedge funds and large institutions have $276M invested in Syros Pharmaceuticals, Inc. Common Stock in 2021 Q2 according to their latest regulatory filings, with 19 funds opening new positions, 48 increasing their positions, 20 reducing their positions, and 25 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
100
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
1
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$893K
Puts
$2.66M
Net Calls
Net Calls Change

Top Buyers

1 +$5.18M
2 +$4.64M
3 +$4.36M
4
OFM
Omega Fund Management
Massachusetts
+$3.88M
5
AG
Artal Group
Luxembourg
+$3.68M

Top Sellers

1 -$57.7M
2 -$38.6M
3 -$37.7M
4
BBA
Baker Bros. Advisors
New York
-$3.4M
5
Citadel Advisors
Citadel Advisors
Florida
-$3.36M
Name Holding Trade Value Shares
Change
Change in
Stake
1
$49.3M
2
$31.5M
3
$24.3M
4
$18.7M
5
$16M
6
$15.1M
7
$12.4M
8
$10.6M
9
$10M
10
$9.27M
11
$5.87M
12
$5.45M
13
$5.45M
14
$5.27M
15
$4.91M
16
$4.64M
17
$4.36M
18
$3.18M
19
$3.04M
20
$3.02M
21
$2.73M
22
$2.2M
23
$2.14M
24
$1.93M
25
$1.68M